Tr1X is a biotechnology company that develops cellular therapies aimed at curing autoimmune and inflammatory diseases. By engineering treatments that induce immune tolerance and restore homeostasis, Tr1X strives to address high unmet medical needs for patients battling debilitating illnesses. Utilizing a state-of-the-art technology platform, the company focuses on scalable solutions that generate engineered living drugs. Tr1X emphasizes a collaborative and inclusive workplace culture, encouraging teamwork and innovation among its diverse workforce. With a commitment to accelerating the development of its therapies, Tr1X seeks individuals who are dedicated to making a meaningful impact in the field of biotechnology.